Flow is also available in the EU, Norway, Hong Kong and Brazil.
Countries where Flow is available.
77%
From our real world data of over 14,000 users. “Clinical improvement” is judged by an internationally recognised and clinically validated scale - the MADRS-s.
See a clinical improvement within 3 weeks
57%
According to the largest ever trial into tDCS which used the Flow headset. Users no longer had depression according to an internationally recognised and clinically validated scale - the MADRS-s.
No longer have depression at 10 weeks
-
Users' most recent depression score, measured by an internationally recognised and clinically validated scale - the MADRS-s.